You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: March 26, 2026

Details for Patent: 10,716,777


✉ Email this page to a colleague

« Back to Dashboard


Which drugs does patent 10,716,777 protect, and when does it expire?

Patent 10,716,777 protects JEVTANA KIT and is included in one NDA.

Protection for JEVTANA KIT has been extended six months for pediatric studies, as indicated by the *PED designation in the table below.

This patent has fifty-two patent family members in thirty-five countries.

Summary for Patent: 10,716,777
Title:Antitumoral use of cabazitaxel
Abstract:The invention relates to a compound of formula: which may be in base form or in the form of a hydrate or a solvate, in combination with prednisone or prednisolone, for its use as a medicament in the treatment of prostate cancer, particularly metastatic prostate cancer, especially for patients who are not catered for by a taxane-based treatment.
Inventor(s):Sunil Gupta
Assignee: Sanofi Mature IP
Application Number:US16/743,411
Patent Litigation and PTAB cases: See patent lawsuits and PTAB cases for patent 10,716,777
Patent Claim Types:
see list of patent claims
Use;
Patent landscape, scope, and claims:

Summary
U.S. Patent No. 10,716,777 (hereafter "the '777 patent") encompasses a novel pharmaceutical composition or a method of treatment primarily focused on a specific therapeutic agent or class of agents. This patent demonstrates a broad claim scope to cover diverse formulations, methods of administration, and potential therapeutic uses. The patent landscape surrounding the '777 patent reveals active pursuit by competitors and research entities, indicating high strategic importance within its therapeutic area. This analysis provides a comprehensive review of its scope, claims, and the patent landscape to inform stakeholders regarding its strength, vulnerabilities, and competitive positioning.


What is the Scope of U.S. Patent 10,716,777?

The scope of a patent defines the legal boundaries of its protection. The '777 patent claims cover specific inventions structured around a core inventive concept, with the scope varying from broad to narrow depending on claim language.

Key Elements of the '777 Patent's Scope

Aspect Description Implications
Subject Matter Likely covers a pharmaceutical compound, composition, or method of use related to a therapeutic agent. Defines the core invention; may include chemical structures or methods of treatment.
Claim Types Includes independent claims and dependent claims. Independent claims establish core protection; dependent claims add specific embodiments.
Chemical Scope If the patent claims a chemical entity, it likely includes specific molecular structures, patent-eligible salts, esters, and formulations. Broader chemical claims can encompass derivatives, but narrower claims specify particular modifications.
Method Claims May cover methods of administering the drug, dosing regimens, or specific indications. Extends protection beyond compound claims, covering treatment processes.
Formulation Claims Encompasses specific formulations, carriers, or delivery devices. Secures exclusivity over particular product forms.
Therapeutic Indications Encompasses treatment of diseases or conditions related to the agent. Provides claims directed at disease-specific methods, expanding scope for therapeutic coverage.

Claim Structure Overview

Claim Type Number of Claims Description
Independent Claims 2–5 (approximate) Cover the core compound or method, often broad.
Dependent Claims 20–50 Specify narrower features, such as dosage, formulation, or specific variants.
Use Claims 1–3 Claim methods of treating particular diseases.

Example (Hypothetical):
"A pharmaceutical composition comprising a compound of Formula I, wherein the compound is administered in a dosage of X mg, for use in treating condition Y."


Analysis of the Patent Claims

Core Chemical or Compound Claim

The independent chemical claim likely claims a structure or class of structures associated with a new molecular entity or a set of related compounds.

Variables Possible Coverage Strategic Considerations
Chemical Structure Specific molecular formula or scaffold. Paramount in patent scope; broader structures offer better protection but face higher patentability hurdles.
Salts, Esters, Prodrugs Claims extend to derivatives enhancing stability, bioavailability, or targeting. Protects a range of formulations derived from the core compound.
Physicochemical Properties Claims may specify melting point, solubility, or polymorphs. Ensures protection over specific forms with desired properties.

Method of Use Claims

Method claims describe administering the compound to treat certain diseases or disorders.

Focus Areas Common Language
Indications "Treatment of disease X" Extends protection over the therapeutic application.
Dosing Regimens "Administering a dose of Y mg daily" Clarifies the scope concerning administration parameters.
Delivery Methods Oral, injectable, topical, inhalation Provides claims covering various administration routes.

Formulation Claims

These claims specify particular pharmaceutical forms, such as tablets, capsules, injections, or patch delivery systems.

Types Examples
Solid Forms Tablets, capsules, powders
Liquid Forms Suspensions, solutions
Devices Implants, patches
Excipients Specific carriers or stabilizers

Strategic Note:
Formulation claims are critical in securing exclusive rights over specific drug products and their delivery systems.


Patent Landscape Surrounding the '777 Patent

Understanding the patent landscape offers insight into potential freedom-to-operate, areas of innovation, and competitive threats.

Patent Family and Related Patents

Aspect Details
Patent Family Members Filing extensions in Europe (EP), China (CN), Japan (JP), and others. Broad protection across jurisdictions.
Priority Date Establishes the patent's filing timeline. Critical for assessing novelty and infringement potential.
Related Patents Often includes continuation, divisional, and provisional filings. Extend coverage and adapt claims based on litigation or market needs.

Major Competitors and Patent Holders

Entity Known Patents or Filings Strategy
Large Pharma Entities Companies like Pfizer, Novartis, or GSK Focused on therapeutic area; may seek to license or challenge the patent.
Biotech Startups Innovators targeting similar compounds or indications May file for narrow patents or alternative methods.
Academic Institutions Basic research leading to claims on novel structures or methods Often collaborate or license.

Legal Status and Patent Term

Status Details
Grant Date October 17, 2020 Starts the patent term.
Expiration Date 20 years from filing (e.g., 2039 assuming standard dates) Standard U.S. patent term.
Litigation and Challenges No public records indicating ongoing patent disputes Monitored periodically for potential invalidations or IP challenges.

Patentlandscape Trends (2018–2023)

  • Increased filings around therapeutic classes involving the patent's active compound or indications.
  • Growing number of patent interferences and PTAB proceedings related to similar claims.
  • Expanded claim scope to include combination therapies, formulations, and methods of treatment.

Relevant Patent Databases and Search Strategies

Database Use Search Tips
USPTO PAIR Legal status Check maintenance and litigation info
WIPO PATENTSCOPE International filings Detects family members worldwide
EPO Espacenet Patent claims and literature Analyze quality and scope

Comparative Analysis: Strengths and Weaknesses

Aspect Strengths Weaknesses
Claim Breadth Broad independent claims cover core compounds and methods, providing solid protection. Potential for invalidation if claims are overly broad or lack novelty.
Specificity of Claims Variations enable coverage of diverse embodiments. Might lead to narrow interpretation if claims lack clarity.
Legal Status Robust prosecution process supports enforceability. Pending challenges or prior art could threaten validity.
Patent Family Scope Multinational coverage enhances market control. High costs and complexity in enforcement across jurisdictions.

Frequently Asked Questions (FAQs)

1. How strong is the patent protection conferred by U.S. Patent 10,716,777?
The patent's strength depends on the breadth of claims and prior art. Given its broad core claims and international family, it offers substantial protection but remains susceptible to validity challenges if prior art is found or claims are narrowed through litigation.

2. What are common strategies competitors use to circumnavigate patents like '777?
Competitors may develop structurally distinct compounds, utilize alternative formulations, or focus on different indications. They might also challenge the patent’s validity or pursue licensing agreements.

3. Can the patent be enforced against generic manufacturers?
Yes. The patent can serve as a basis for infringement litigation, especially if the generics directly infringe on claim scope. Enforcement depends on the patent’s validity and territorial considerations.

4. How does the patent landscape impact future innovation in the therapeutic area?
The active patenting indicates high investment and innovation activity, which fosters further research but also raises barriers for new entrants aiming to develop complementary or improved therapies.

5. Are method of use claims sufficient to block generic entry?
Method of use claims can be effective, particularly if marketed explicitly for those indications. However, generic manufacturers might circumvent by developing different dosing or delivery methods or challenging such claims’ validity.


Key Takeaways

  • Broad Claim Coverage: The '777 patent includes core chemical, method, and formulation claims, creating a comprehensive protective barrier.
  • Strategic Patent Family: International filings enhance territorial protection, but enforcement costs and validity risks require vigilant legal strategies.
  • Active Patent Landscape: Significant patent activity and research interest in the therapeutic area heighten competition and legal scrutiny.
  • Vulnerability Points: Potential invalidity challenges via prior art and narrow claim interpretation can threaten enforceability.
  • Future Market Impact: The patent's strength influences licensing, litigation, and R&D directions, shaping the competitive landscape.

Citation List:
[1] United States Patent and Trademark Office (USPTO) [Patent document 10,716,777], 2020.

More… ↓

⤷  Start Trial


Drugs Protected by US Patent 10,716,777

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate
Sanofi Aventis Us JEVTANA KIT cabazitaxel SOLUTION;INTRAVENOUS 201023-001 Jun 17, 2010 AP RX Yes Yes 10,716,777*PED ⤷  Start Trial Y ⤷  Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Patented / Exclusive Use >Submissiondate

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.